CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Call for Feedback: Early Identification of Stroke

January 17, 2020
A new project on Early Identification of Stroke is now available for feedback from all interested stakeholders. Early Identification of Stroke Call for Feedback: 2020-01-17 Feedback Due By: 2020-01-31 Consultation Document: Horizon Scanning Report Product Type: Issues in Emerging Health Technologies Submit Feedback

New at CADTH — January 2020

January 10, 2020
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

CADTH Pharmaceutical Reviews Update — Issue 12

January 9, 2020
See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: A new process for the submission and review of cell and gene therapies Updated guidelines on fees for CADTH pharmaceutical reviews Pending updates to the category 1 r...

Drug Reimbursement Recommendation - inotersen (Tegsedi)

December 20, 2019
Today, CADTH has issued final recommendations for: inotersen (Tegsedi) Indications: hereditary transthyretin amyloidosis Recommendation: Reimburse with clinical criteria and/or conditions For more information

New at CADTH — December 2019

December 9, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.